JCR Pharmaceuticals Co., Ltd. provided earnings guidance for the fiscal year ending March 31, 2022. For the year, the company expects Net sales of JPY 49,000 million, Operating income of JPY 18,700 million, Ordinary income of JPY 18,700 million and Earnings per share of JPY 107.68.